Europe Startup Funding Rounds
Startups raising capital across Europe. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 1,483 Jan 1 – Oct 25, 2026
- Disclosed funding
- $63.5B 1206 disclosed amounts
- Median round
- $6.9M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
iPremomCompany profile iPremom offers MaiRa, a clinician-prescribed prenatal blood test that estimates a pregnant woman’s risk of preeclampsia from week 9. It analyzes cell-free RNA in maternal blood with a proprietary predictive algorithm, giving obstetric teams an early risk report to guide monitoring and preventive decisions; it is a risk-assessment tool, not a diagnostic test. iPremom offers MaiRa, a clinician-prescribed prenatal blood test that estimates a pregnant woman’s risk of preeclampsia from week 9. It analyzes cell-free RNA in maternal blood with a proprietary predictive algorithm, giving obstetric teams an early risk report to guide monitoring and preventive decisions; it is a risk-assessment tool, not a diagnostic test. | €15M | Seed | Healthtech | Spain | Investors | |
DataHowCompany profile DataHow builds DataHowLab, a process-modeling and digital-twin platform for biopharmaceutical process engineers and manufacturers. DataHow builds DataHowLab, a process-modeling and digital-twin platform for biopharmaceutical process engineers and manufacturers. | Undisclosed | Bridge financingUndisclosed | Enterprise software | Switzerland | Investors | |
iPRONICSCompany profile iPRONICS builds silicon-photonics optical circuit switches that let AI data centers reconfigure high-bandwidth connections between compute systems across and within racks. iPRONICS builds silicon-photonics optical circuit switches that let AI data centers reconfigure high-bandwidth connections between compute systems across and within racks. | $125M | Series B | Hardware | Spain | Investors | |
NovaGo TherapeuticsCompany profile NovaGo Therapeutics is a clinical-stage biotech developing anti-Nogo-A antibodies intended to promote nerve regeneration and functional recovery after central nervous system injury. NovaGo Therapeutics is a clinical-stage biotech developing anti-Nogo-A antibodies intended to promote nerve regeneration and functional recovery after central nervous system injury. | CHF 24M | Series B | Biotech | Switzerland | Investors | |
InstarcCompany profile Instarc provides configurable compliance software for regulated financial businesses and other organisations subject to South Africa’s FICA rules. The platform connects digital client onboarding, identity and ownership verification, KYC/CDD checks, document collection, case workflows and retrievable audit records with existing systems, helping teams run ongoing compliance as a structured process. Instarc provides configurable compliance software for regulated financial businesses and other organisations subject to South Africa’s FICA rules. The platform connects digital client onboarding, identity and ownership verification, KYC/CDD checks, document collection, case workflows and retrievable audit records with existing systems, helping teams run ongoing compliance as a structured process. | €1.3M | Strategic investmentGrowth | Fintech | Estonia | Investors | |
ReapitCompany profile A real-estate agency platform that connects sales, lettings, property management and client-account workflows with the buyers, sellers, tenants and landlords agencies serve. A real-estate agency platform that connects sales, lettings, property management and client-account workflows with the buyers, sellers, tenants and landlords agencies serve. | >£20M | Growth investmentUndisclosed | Proptech | United Kingdom | Investors | |
PLD SpaceCompany profile PLD Space develops reusable space-transport systems for satellite operators and institutional customers. PLD Space develops reusable space-transport systems for satellite operators and institutional customers. | €108M | Series C extensionSeries C+ | Space tech | Spain | Investors | |
| AT Amyl TherapeuticsCompany profile Amyl Therapeutics is developing immunotherapies that target amyloid aggregates linked to neurodegenerative disease. Amyl Therapeutics is developing immunotherapies that target amyloid aggregates linked to neurodegenerative disease. | €8.3M | Series A extensionSeries A | Biotech | Belgium | Investors | |
INLEAP PhotonicsCompany profile INLEAP Photonics develops precision laser-beam steering for industrial processing and counter-drone defense. INLEAP Photonics develops precision laser-beam steering for industrial processing and counter-drone defense. | ~€20M | Seed | Defense tech | Germany | Investors | |
NovumstateCompany profile A German property-management group that acquires residential property managers and supports their digital transformation, giving owners and managers a more scalable way to run building services. A German property-management group that acquires residential property managers and supports their digital transformation, giving owners and managers a more scalable way to run building services. | Undisclosed | Undisclosed investmentUndisclosed | Proptech | Germany | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1High-Tech Gründerfonds
Rabot Energy, TODAY, Finches
39rounds4led - 2Antler
Jenz, Affinity Labs, CodeWall
26rounds0led - 3Y Combinator (YC)
HyLight, Sensible Biotechnologies, Revnu
22rounds1led - 4General Catalyst
Legora, Complir, Integral
21rounds1led - 5Index Ventures
Opply, Duvo, Spiko
21rounds2led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.